학술논문
Acalabrutinib and high-frequency low-dose subcutaneous rituximab for initial therapy of chronic lymphocytic leukemia
Document Type
Article
Author
Source
In Blood Advances 13 June 2023 7(11):2496-2503
Subject
Language
ISSN
2473-9529